Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Newsfile 8 days ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

PR Newswire 9 days ago

Innovative Medical Technology Advances with First Patient Enrollments

Newsfile 10 days ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

PR Newswire 11 days ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

PR Newswire November 6, 2024

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

PR Newswire October 8, 2024

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Newsfile September 19, 2024

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

PR Newswire September 19, 2024

Aethlon Medical to Present at Virtual Investor Conferences in September

PR Newswire September 17, 2024

Innovation Driving Cancer's Solid Tumors Market

Newsfile September 17, 2024

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

PR Newswire September 16, 2024

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

PR Newswire August 27, 2024

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

PR Newswire August 14, 2024

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Newsfile August 12, 2024

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

PR Newswire August 12, 2024

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

PR Newswire August 6, 2024

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

PR Newswire June 27, 2024

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

PR Newswire June 21, 2024

What's Next in Treatments for Cancer Patients with Solid Tumors?

Newsfile June 20, 2024

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

PR Newswire June 18, 2024